# DAVIS v. WETZEL

> District Court, M.D. Pennsylvania · July 6, 2022

URL: https://www.frixlaw.com/law-library/cases/10411916

## Case

- **Court:** District Court, M.D. Pennsylvania
- **Decided:** July 6, 2022
- **Opinion:** 100trialcourt
- **Cited by:** 0 later opinions in the Frix Law Library

## Citator (automated)

- No negative treatment found by the automated citator. That is not the same as a confirmation that the case is good law; read the citing cases.
- Full citator and citing cases: https://www.frixlaw.com/law-library/cases/10411916

## How later opinions describe it (automated extraction)

- holding that plaintiff “did not take full advantage of the administrative procedures available to him” in failing to use steps two and three of DC-ADM 804

## Opinion text

UNITED STATES DISTRICT COURT
MIDDLE DISTRICT OF PENNSYLVANIA
KEVIN DAVIS,

Plaintiff, CIVIL ACTION NO. 1:18-CV-00804

v. (MEHALCHICK, M.J.)

JOHN WETZEL, et al.,

Defendants.

MEMORANDUM
Pro se prisoner-Plaintiff Kevin Davis (“Davis”) initiated this civil rights action by filing
a complaint on October 27, 2017, pursuant to 42 U.S.C. § 1983. (Doc. 5). In his second
amended complaint, Davis brings an Eighth Amendment deliberate indifference claim
against the following Defendants: John E. Wetzel (“Wetzel”), Secretary of the Pennsylvania
Department of Corrections (“DOC”); Paul A. Noel, M.D. (“Dr. Noel”), Chief of Clinical
Services of the DOC’s Bureau of Healthcare Services; John Steinhart, Assistant Medical
Director of the Bureau of Health Care Services; Rich Wenhold, Coordinator of Infection
Control for the Bureau of Healthcare Services; Correct Care Solutions, LLC (“CCS”), the
contracted healthcare provider for the Department of Corrections; Dr. Jay Cowan (“Dr.
Cowan”), a CCS representative; Joseph Silva, Director of the DOC’s Bureau of Health Care
Services; Nedra Grego (“Grego”),1 Corrections Healthcare Administrator at SCI-Fayette; N.
Ranker, an infectious care nurse at SCI-Fayette; and John Doe, Chief Counsel for the
Hepatitis C Treatment Committee. (Doc. 112, at 2-4). Davis alleges that all Defendants are

1 Although this Defendant is currently known as Nedra Rice (Doc. 89, at 1), for the
purposes of this memorandum the Court will continue to refer to her by her former last name:
Grego.
members of the Hepatitis C Treatment Committee (“the Committee”), which has adopted a
policy in violation of the Eighth Amendment and rejected his request for treatment for
nonmonetary reasons in deliberate indifference to his serious medical need to be treated for
Hepatitis C. (Doc. 112, at 2-5). The parties have consented to proceed before the United States

Magistrate Judge pursuant to 28 U.S.C. § 636(c) and Rule 73 of the Federal Rules of Civil
Procedure. (Doc. 20; Doc. 33; Doc. 44; Doc. 65).
A non-jury trial was conducted before Chief Magistrate Judge Karoline Mehalchick
on May 23, 2022. (Doc. 218; Doc. 226). Defendants were represented by counsel and Davis
represented himself pro se. (Doc. 226). Both parties presented testimony and evidence at trial,
and both parties filed proposed finding of fact and conclusions of law following trial. 2 (Doc.
221; Doc. 225). Based on these submissions, the Court must determine whether the DOC
Defendants provided misleading information to Davis that rendered the PLRA exhaustion of
administrative remedies process “unavailable” to him.

The Court, having heard the testimony and reviewed all documentary evidence, now
enters the following Findings of Fact, Conclusions of Law, and Decision pursuant to Rule 52
of the Federal Rules of Civil Procedure. Fed. R. Civ. P. 52.
FINDINGS OF FACT
The following findings of fact are based upon the parties’ filings, as well as the
testimony and evidence that the Court found credible as presented at trial.

2 At the non-jury trial, Davis sought to make an oral motion to prevent DOC
Defendants from using and referring to Davis’s medical records to rebut the injuries Davis
allegedly sustained. (Doc. 226, at 53-54, Tr. of Trial, 53:20-54:2, May 23, 2022). The Court
construes Davis’s proposed motion as a motion in limine taking issue with potential evidence
that may be used at a later trial. (Doc. 226, at 55, Tr. of Trial, 55:17-25, May 23, 2022). Such
evidentiary issues may be raised in the future as the parties prepare for trial. (Doc. 226, at 55,
Tr. of Trial, 55:17-25, May 23, 2022).
1. The Plaintiff is Kevin Davis, an inmate currently incarcerated within the
Pennsylvania DOC at the State Correctional Institute at Fayette (“SCI-Fayette”).
(Doc. 112, at 2).
2. The remaining Defendants are Paul A. Noel, M.D.; Rich Wenhold; and John E.

Wetzel. (Doc. 112, at 2-3).
3. On January 31, 2017, Davis submitted a DC-135A informal inmate request to staff
form addressed to Superintendent Lane. (Doc. 227-1, at 1). In the letter, Davis
stated: “The federal court has ruled that we must be treated for [Heptaitis C]. Please
explain why I have not been offered with this drug Harvoni or the drug that cures
the same way I’ve been offered the programs. In the alternative, direct medical
institute treatment for the juveniles.”3 (Doc. 227-1, at 1).
4. On February 6, 2017, Ranker issued a response on Superintendent Lane’s behalf,
stating that Davis’s “labs and testing have been [forwarded] to the Hepatitis-C

3 Davis is referring to United States District Judge Mariani’s decision in Abu-Jamal v.
Kerestes, No. 3:15-CV-00967, 2016 WL 4574646 (M.D. Pa. Aug. 31, 2016). (Doc. 227, at 1;
Doc. 227-1, at 6). In Abu-Jamal, the Court found that the “DOC has an interim protocol to
address patients with hepatitis C” and that, under that protocol, a “Hepatitis C Treatment
Committee has the ultimate authority to decide whether” an inmate is treated with recently
developed direct-acting antiviral (“DAA”) medications. 2016 WL 4574646, at *5, 8. The
Court concluded that “[t]he protocol as currently adopted and implemented presents
deliberate indifference to the known risks which follow from untreated chronic hepatitis C.”
Abu-Jamal, 2016 WL 4574646, at *9. However, the Court did not issue a preliminary
injunction because “[i]t was the Hepatitis C Treatment Committee who made the decision
not to give Plaintiff DAA medications and that had, and continues to have, the ultimate
authority to determine whether or not Plaintiff will receive the DAA medications,” and “[t]he
named Defendants [were] not members of the Hepatitis C Treatment Review Committee.”
Abu-Jamal, 2016 WL 4574646, at *9. Indeed, based upon these findings the Court
subsequently entered a preliminary injunction, enjoining reliance upon the Committee’s
treatment protocol. See Abu-Jamal v. Wetzel, No. 3:16-CV-2000, 2017 WL 34700, at *20 (M.D.
Pa. Jan. 3, 2017), appeal dismissed sub nom. Abu-Jamal v. Sec'y PA Dept. of Corr, No. 17-1125,
2017 WL 3123434 (3d Cir. Apr. 13, 2017), and appeal dismissed sub nom. Abu-Jamal v. Sec'y PA
Dept. of Corr, No. 17-1156, 2017 WL 3160959 (3d Cir. Apr. 14, 2017).
Committee in Central Office.” (Doc. 227-1, at 1). Ranker stated that “the
Committee determines the plan of action as far as where you fall in the plan for
treatment.” (Doc. 227-1, at 1).
5. On February 10, 2017, Davis filed Grievance 664288, which stated:

The SCI Fayette has a policy not to treat prisoners in their care, custody
and control who have the Hepatitis C virus, notwithstanding a court
ruling for the DOC to provide the latest antiviral medication that cures
the illness before advanced liver damage.

On February 6, 2017, in response to the undersigne[d] inquiry for
treatment with HARVONI/medication that has been found to cure
Hepatitis C, the undersign[ed] was advised that a committee in on at the
SCI Fayette has not decided on treatment for the undersign[ed],
notwithstanding the federal courts have ruled that treatment must be
provided before advanced liver damage and the DOC must provide the
latest antiviral medication that cures the illness.

(Doc. 227, at 2).
6. Davis did not request monetary damages in the initial filing of Grievance 664288.
(Doc. 227, at 2).
7. The initial grievance form of Grievance 664288 contains the following instruction:
Refer to the DC-ADM 804 for procedures on the Inmate Grievance
System. State your grievance in Block A in a brief and understandable
manner. List in Block B any action you may have taken to resolve this
matter. Be sure to include the identity of staff members you have
contacted. [. . .] Provide a brief clear statement of your grievance. [. . .]
State all relief that you are seeking.

(Doc. 226, at 14-15, Tr. of Trial, 14:25-15:9 (emphasis added); Doc. 227,
at 2).

8. On March 7, 2017, an Initial Review Response to the grievance denied the
grievance because “[t]here is a policy in place for the [DOC] regarding the
treatment of inmates with Hepatitis C,” and the Hepatitis C Treatment Committee
found that Davis did not meet the required criteria to be approved for treatment
upon review of Davis’s lab work and testing. ((Doc. 227, at 5).
9. Appealing the initial denial, Davis argued that he be treated “with the new drug
that cures [Hepatitis C] before liver damage occurs,” in accordance with Judge
Mariani’s ruling. (Doc. 227, at 6).

10. Davis requested monetary damages in the initial appeal of Grievance 664288.
(Doc. 227, at 6).
11. On March 24, 2017, Joseph Trempus, Major of Unit Management, upheld the
initial denial of the grievance. (Doc. 227, at 7).
12. Davis filed a final appeal of the grievance to the Secretary’s Office of Inmate
Grievances & Appeals (“SOIGA”) on March 28, 2017. (Doc. 227, at 8).
13. On April 13, 2017, SOIGA referred Grievance 664288 to the Bureau of Health
Care Services. (Doc. 227, at 4).
14. On May 17, 2017, the Bureau of Health Care Services wrote to SOIGA regarding
its review of the grievance, stating that the Bureau determined that the medical care

provided to Davis was reasonable and appropriate, that Davis was not a candidate
for treatment, and that there is no evidence of neglect or deliberate indifference.
(Doc. 227, at 3).
15. The Final Appeal Decision was issued on May 31, 2017, upholding the lower
denials of the grievance and finding as follows:
Your issue with not being provided proper medical care for Hepatitis C
was reviewed by the staff at the Bureau of Health Care Services. The
BHCS reviewed the medical record and determined the medical care
provided was reasonable and appropriate. The DOC has updated its
protocol for treating Hepatitis C. You are not currently a candidate for
treatment in accordance with the protocol and will continue to be
monitored in chronic clinic as determined by your treatment plan. There
is an orderly progression that is required before treatment with certain
tests, etc. so, as you move ahead, you will be included in these tests as
part of your work up prior to treatment. You are encouraged to
participate in your treatment plan and to discuss your concerns or
changes with a practitioner. There is no evidence of neglect or deliberate
indifference has been found. Therefore, your requested relief is denied.

(Doc. 112, at 23).
16. On October 30, 2017, Davis initiated this civil rights action by filing a complaint
pursuant to 42 U.S.C. § 1983, alleging claims under the Eighth Amendment for
deliberate indifference regarding his treatment for Hepatitis C. (Doc. 5; Doc. 112).
17. On October 22, 2018, the Court granted two motions to dismiss that had been filed
by CCS, dismissing the original complaint without prejudice. (Doc. 85; Doc. 86).
The Court found that Davis failed to adequately plead how Defendants Wetzel,
Ranker, and Grego were personally involved in the constitutional wrongdoings he
alleged. (Doc. 85, at 5-10). The Court also found that Davis failed to demonstrate
how CCS established a policy, custom, or practice that gave rise to the Eighth
Amendment violations he complained of, as required for Monell liability under §
1983. (Doc. 85, at 10-13); see Monell v. Dep't. of Soc. Servs. of City of New York, 436
U.S. 658, 694 (1978).
18. Davis filed the amended complaint on November 13, 2018. (Doc. 87).
19. On November 27, 2018, Defendants Grego, Noel, Ranker, Wetzel, and Silver
(“DOC Defendants”) filed a partial motion to dismiss the amended complaint.
(Doc. 89). On February 15, 2019, the Court granted the motion to dismiss and
granted Davis leave to file a second amended complaint. (Doc. 104; Doc. 105).
This Court found that Davis failed to demonstrate how CCS established a policy,
custom, or practice giving rise to Monell liability under § 1983 and that Davis failed
to allege that Defendants Ranker and Grego acted with deliberate indifference.
(Doc. 105).
20. On February 27, 2019, Davis filed the second amended complaint, challenging the
constitutionality of the DOC’s interim Hepatitis C policy. (Doc. 112). Davis alleges

that all Defendants are members of the Hepatitis C Treatment Committee that is
responsible for adopting the Hepatitis C policy. (Doc. 112, at 2-5, 9-11). Davis
claims that the Hepatitis C policy prevents inmates without “vast fibrosis or
cirrhosis or who do have fibrosis or cirrhosis” from receiving direct-acting antiviral
drug (“DAAD”) medications. (Doc. 112, at 5). Davis also asserts that the Hepatitis
C policy is deliberately indifferent to the known risk that he, and other prisoners
with Hepatitis C, will continue to suffer from complications including ascites,
portal hypertension, hepatic encephalopathy, and esophageal varices. (Doc. 112,
at 1, 5, 9). Davis challenges the application of the policy and the decision to deny
him DAAD treatment despite his serious illness. (Doc. 112, at 1, 9-12). Due to

Defendants’ refusal to treat Davis with the DAAD medications he requested,
Davis alleges that he suffers from liver damage, abdominal pain, daily rectal
bleeding, fainting spells, and a skin condition. (Doc. 112, at 10-11). Davis claims
that the consequence of their policies and customs is that patients, including
himself, suffer declining health including liver damage, abdominal pain, rectal
blood flow, passing out, and skin conditions. (Doc. 112, at 11).
As for relief, Davis seeks declaratory judgment that Defendants violated his
“Eighth Amendment right to medical care for Hepatitis C.” (Doc. 112, at 12). He
also seeks to enjoin the use of the DOC’s Hepatitis C policy, receive the curative
DAAD medication he requested, and obtain immediate treatment for his Hepatitis
C-related skin complications. (Doc. 112, at 12). Davis additionally seeks monetary
damages for the harm caused to his liver by effectively ignoring his request for
Hepatitis C treatment and leaving his condition untreated. (Doc. 112, at 12).

21. On March 25, 2019, DOC Defendant filed an answer to the second amended
complaint and raised the affirmative defense of failure-to-exhaust. (Doc. 113). On
November 20, 2019, DOC Defendants filed a motion for summary judgment.
(Doc. 142). On July 6, 2020, the Court granted the motion in part and denied it in
part. (Doc. 158; Doc. 159). Specifically, the Court granted the motion with respect
to Defendants Grego, Ranker, Steinhart, and Silva, and denied the motion with
respect to Defendants Wetzel, Dr. Noel, and Wenhold. (Doc. 158; Doc. 159). On
March 12, 2021, Defendants CCS and Dr. Cowan filed a motion for summary
judgment. (Doc. 184). On December 23, 2021, the Court granted the motion in
favor of CCS and Dr. Cowan, dismissing them from this action. (Doc. 203; Doc.

204). On February 2, 2022, the Court issued an order scheduling a trial by jury to
commence on August 29, 2022. (Doc. 206).
22. On February 7, 2022, the remaining DOC Defendants, Dr. Noel, Wenhold, and
Wetzel, filed the motion to bifurcate these proceedings and conduct an initial non-
jury trial on the issue of Davis’s failure to properly exhaust administrative
remedies, in advance of the jury trial scheduled on the remaining claims. (Doc.
207).
23. The non-jury trial was held on May 23, 2022, at which both parties presented
witness testimony. (Doc. 218).
24. At the non-jury trial, DOC Defendants offered the testimony of Rhonda House,
the DOC Superintendent’s Assistant and Facility Grievance Coordinator at SCI-
Fayette, and Davis offered his own testimony. (Doc. 226, at 4, 22, Tr. of Trial,
4:11, 22:9, May 23, 2022).

25. As the Grievance Coordinator, House has access to inmates’ grievances and their
grievance histories. (Doc. 226, at 11, Tr. of Trial, 11:3-5, May 23, 2022). House’s
responsibilities include reading the grievances, making sure it is written in
compliance with DOC policies, assigning the grievance to a Lieutenant or other
appropriate staff member, and either approving the responses or suggesting
changes before entering all the information into the Grievance Tracking System.
(Doc. 226, at 10, Tr. of Trial, 10:16-24, May 23, 2022).
26. House testified that the current version of the Pennsylvania DOC Inmate
Handbook is the 2017 edition, which in effect at all times relevant to this action.
(Doc. 226, at 5, Tr. of Trial, 5:25-6:7, May 23, 2022). All inmates are provided

with a copy of the inmate handbook when they first come into the DOC. (Doc.
226, at 6, Tr. of Trial, 6:8-13, May 23, 2022).
27. House testified that the inmate Handbook does not contain the full versions of
DOC policies, but inmates are able to obtain the full version of the policies by
making a request with the library or housing units. (Doc. 226, at 7, Tr. of Trial,
7:11-17, May 23, 2022).
28. House testified that inmates are advised that they are responsible for following the
full versions of all DOC policies and procedures that apply to them. (Doc. 226, at
7, Tr. of Trial, 7:20-25, May 23, 2022).
29. Reading from the Inmate Handbook, House offered testimony that the handbook
directs inmates that: “This handbook provides general information regarding
[DOC] policies and procedures. When DOC policies are changes, you will be given
notice of the changes of the most current policy will become effective, regardless

of what information is in this handbook. You are to keep this handbook until you
are released. If it is lost or destroyed, you may purchase a new one.” (Doc. 226, at
7, Tr. of Trial, 7:4-10, May 23, 2022).
30. House testified that Page 9 of the Inmate Handbook cites to DOC policy DC-ADM
804 (effective May 1, 2015), captioned Inmate Grievance System (“IGS”), which
sets forth the relevant procedures for inmates to file a grievance. (Doc. 226, at 8-9,
Tr. of Trial, 8:23-9:10).
31. Courts may take judicial notice of the Pennsylvania DOC’s 2017 Inmate
Handbook (effective May 1, 2015) and policy statement, DC-ADM 804. See Ali v.

Superintendent SCI Camp Hill, No. 1:14-CV-1851, 2015 WL 5913197, at *3 (M.D.
Pa. Oct. 7, 2015) (internal citations omitted).
32. The IGS requires a concern about prison life to be filed initially with the Facility
Grievance Coordinator. DC-ADM 804 § 1(A)(5). Specific requirements of what
the inmate must state in a grievance are identified in DC-ADM 804 § 1(A)(11),
including a requirement that “if the inmate desires compensation or other legal
relief normally available from a court, the inmate must request the specific relief
sought in his/her initial grievance.” DC-ADM 804 § 1(A)(11)(d). If the inmate
receives an unfavorable response to his initial filing, he must appeal within fifteen
working days to the Facility Manager. DC-ADM 804, § 2(A)(1)(a-b). If the inmate
receives an unfavorable response from the Facility Manager's review, he must
appeal within fifteen working days to the Final Review. DC-ADM 804, §
2(B)(1)(b). A proper appeal to Final Review must include a written appeal to the
SOIGA. DC-ADM 804 § 2(B)(1)(j)(5).

33. House testified that Davis previously filed the following grievances in which he
requested monetary relief: (1) Grievance 501173, which was filed on March 13,
2014; (2) Grievance 516412, which was filed on June 28, 2014; (3) Grievance
531519, which was filed on October 11, 2014; and (4) Grievance 621833, which
was filed on April 14, 2015. (Doc. 226, at 11-13, Tr. of Trial, 11:18-13:21, May 23,
2022).
34. Referring to Davis’s grievance history, House testified that Davis has only filed one
grievance regarding Hepatitis C treatment – Grievance 664288. (Doc. 226, at 13-
14, Tr. of Trial, 13:22-14:2, May 23, 2022).
35. House testified that the DC-804, Part 1 grievance form utilized by Davis to file

Grievance 664288 informs inmates to “[r]efer to the DC-ADM 804 for procedures
on the Inmate Grievance System. State your grievance in Block A in a brief an
understandable manner. List in Block B any action you may have taken to resolve
this matter. Be sure to include the identity of staff members you have contacted.”
(Doc. 226, at 14-15, Tr. of Trial, 14:9-15:4, May 23, 2022; Doc. 227, at 2). In
addition, House testified that Section A of the form stated: “Provide a brief clear
statement of your grievance. . . . State all relief that you are seeking.” (Doc. 226, at
15, Tr. of Trial, 15:5-9, May 23, 2022; Doc. 227, at 2).
36. House testified that Grievance 664288 sought treatment for Davis’s Hepatitis C
and that there are no requests for compensation in Grievance 664288. (Doc. 226,
at 15, Tr. of Trial, 15:12, May 23, 2022; Doc. 227, at 2).
37. House further testified that there are no requests for compensation in the initial

filing of Grievance 664288. (Doc. 226, at 15, Tr. of Trial, 15:16-17, May 23, 2022;
Doc. 227, at 2).
38. Offering is own testimony, Davis testified that there is no request for monetary
damages in the initial filing of Grievance 664288. (Doc. 226, at 26, Tr. of Trial,
26:1-10, May 23, 2022).
39. Davis testified at the non-jury trial that DOC Defendants made representations
that “thwarted” his ability to exhaust administrative remedies. (Doc. 226, at 26,
Tr. of Trial, 26:11-24, May 23, 2022).
40. At the non-jury trial, Davis testified that DOC Defendants “thwarted” his ability
to request monetary relief because DOC Defendants placed him under the

impression that he did not have to request monetary damages because his request
for Hepatitis C treatment would be sent to the Committee. (Doc. 226, at 28, Tr. of
Trial, 28:17-23, May 23, 2022).
41. Davis testified that based on Rankin’s response to Davis’s DC-135A informal
inmate request to staff letter, he was under the assumption that SCI-Fayette did not
provide Hepatitis C treatment. (Doc. 226, at 22-23, Tr. of Trial, 22:18-23:14, May
23, 2022).
42. Davis testified that he decided to file Grievance 664288 in an attempt to determine
who was on the Committee and formally request Hepatitis C treatment. (Doc. 226,
at 23, Tr. of Trial, 23:15-21, May 23, 2022).
43. Davis explained that Grievance 664288 does not request monetary damages

because he was under the assumption that “they w[ere] giving everybody the
programs and all this stuff, and [he was] asking for just the treatment. . . .” (Doc.
226, at 30, Tr. of Trial, 30:6-13, May 23, 2022).
44. Davis testified that after Grievance 664288 was initially denied, he “realized that
something else was going on, [he] started asking them for funds. [He] said if [he]
get[s] hurt from what you all doing, [he] deserve[s] funds.” (Doc. 226, at 33, Tr. of
Trial, 33:4-6, May 23, 2022).
45. Davis sought monetary relief in each appeal of Grievance 664288 filed thereafter.
(Doc. 227, at 6, 8).
46. Davis contends that DOC Defendants misled him by addressing Grievance 664288

on the merits “even after [Davis] mentioned the funds in the appeal to the
Superintendent.” (Doc. 226, at 27, Tr. of Trial, 27:5-20, May 23, 2022).
47. Davis argues that DOC Defendants should have rejected his grievance for failure
to comply with DC-ADM 804, as opposed to denying it on the merits. (Doc. 221,
at 8; Doc. 226, at 29, 31, Tr. of Trial, 29:18-23, 31:9-17, May 23, 2022).
48. Davis testified that “if [DOC Defendants] addressed it on the merits, all the way
up until now . . . that exhaustion procedure is completed . . . .” (Doc. 226, at 31,
Tr. of Trial, 31:12-13, May 23, 2022).
49. Davis argues that DOC Defendants’ failed to raise the failure-to-exhaust defense
until the motion to bifurcate was filed on February 7, 2022, four and a half years
after Davis initiated this matter. (Doc. 5; Doc. 207; Doc. 226, at 30-31, Tr. of Trial,
30:23-31:8, May 23, 2022).
CONCLUSIONS OF LAW

The Court has jurisdiction over the instant action under 28 U.S.C. § 1331. The Court
has federal question jurisdiction over this action as Davis filed the complaint pursuant to 42
U.S.C. § 1983 and the Eighth Amendment. (Doc. 112); 28 U.S.C. § 1331. Venue is proper in
this Court as this suit has been brought in the district where the events giving rise to the claims
occurred. 28 U.S.C. §§ 1391(b)(1), 1391(b)(2).
I. EXHAUSTION OF ADMINISTRATIVE REMEDIES
1. In 1996, Congress enacted the Prison Litigation Reform Act of 1995 (“PLRA”). 42
U.S.C. § 1997e. The PLRA mandates that prisoners exhaust all available

administrative remedies prior to initiation of a suit under § 1983 for deprivation of
Constitutional rights. 42 U.S.C. § 1997e(a). Previously discretionary, the PLRA made
unexhausted claims unreviewable by the District Courts. See Booth v. Churner, 532 U.S.
731, 739 (2001). Although exhaustion is mandatory under the PLRA, proper
exhaustion is an affirmative defense that must be pleaded and proven by the defendant.
Ahmed v. Dragovich, 297 F.3d 201, 209 (3d Cir. 2002); see also Ray v. Kertes, 285 F.3d
295 (3d Cir. 2002).
2. Exhaustion is a precondition to a Section 1983 suit, constituting a “threshold question
that courts must address to determine whether litigation is being conducting in the right

forum at the right time.” Small v. Camden Cty., 728 F.3d 265, 270 (3d Cir. 2013)
(emphasis in original) (citing Drippe v. Tobelinski, 604 F.3d 778, 781 (3d Cir. 2010)); see
also Drippe, 604 F.3d at 781 (“Juries decide cases, not issues of judicial traffic control.
Until the issue of exhaustion is resolved, the court cannot know whether it is to decide
the case or the prison authorities are to.”) (quoting Pavey v. Conley, 544 F.3d 739, 741

(7th Cir. 2008) ); cf. Wilkerson v. United States, Civil Action No. 3:13-1499, 2014 WL
1653249, at *9 (M.D. Pa. Apr. 24, 2014) (“[I]f there is a dispute of material fact, the
court should conduct a plenary trial on the contested facts prior to making [an
exhaustion of administrative remedies] determination.”) (addressing a prisoner's
FTCA claim).
3. “Although the availability of administrative remedies to a prisoner is a question of law,
it necessarily involves a factual inquiry.” Small, 728 F.3d at 271 (citations omitted).
Therefore, “exhaustion is a question of law to be determined by a judge, even if that
determination requires the resolution of disputed facts.” Small, 728 F.3d at 269.

4. The burden to plead and prove failure to exhaust as an affirmative defense rests on the
defendant. Rinaldi v. United States, 904 F.3d 257, 268 (3d Cir. 2018) (citing Ray, 285
F.3d at 295).
5. Once the defendant has established that the inmate failed to resort to administrative
remedies, the onus falls on the inmate to show that such remedies were unavailable to
him. Rinaldi, 904 F.3d at 268 (citing Tuckel v. Grover, 660 F.3d 1249, 1253-54 (10th Cir.
2011)).
6. Even where the relief sought is unavailable through administrative remedies, prisoners
must pursue their claims through prison channels prior to initiation of litigation in

federal courts. See Woodford v. Ngo, 548 U.S. 81, 85 (2006). Courts within the Third
Circuit and the Middle District have consistently imposed a procedural default
component on the exhaustion requirement that requires inmates to “fully satisfy the
administrative requirements of the inmate grievance process before proceeding into
federal court.” McClintic v. Bickell, No. 1:14-CV-2005, 2015 WL 4207229, *3 (M.D. Pa.

July 10, 2015) (citing Spruill v. Gillis, 372 F.3d 218 (3d Cir. 2004)). “Inmates who fail
to fully, or timely, complete the prison grievance process, or who fail to identify the
named defendants, are barred from subsequently litigating claims in federal court.”
McClintic, 2015 WL 4207229, at *3 (citing Spruill, 372 F.3d 218). Indeed, an “untimely
or otherwise procedurally defective administrative grievance” fails to satisfy the
exhaustion requirement of the PLRA and the failure to properly “exhaust
administrative remedies” is a bar to “filing suit in federal court.” See Woodford, 548
U.S. at 83-84, 92.
7. The version of DC-ADM 804 in effect when Davis filed his initial grievance provides

a three-step process, and an inmate must follow each of the steps in order to exhaust
his administrative remedies under the PLRA. See Booth v. Churner, 206 F.3d 289 299,
(3d Cir. 2000) (holding that plaintiff “did not take full advantage of the administrative
procedures available to him” in failing to use steps two and three of DC-ADM 804);
see also Jackson v. Carter, 813 F. App'x 820, 823 (3d Cir. 2020) (“The DOC has a
grievance policy involving a three-step process that an inmate must fully complete in
order to properly exhaust his administrative remedies under the PLRA.”). Grievances
that are not properly submitted in accordance with DC-ADM 804 must be rejected, at
which point the inmate may resubmit the grievance or appeal the rejection. Freeman v.
Wetzel, No. 2:17-CV-1506, 2020 WL 6730897, at *10 (W.D. Pa. Aug. 6, 2020), report
and recommendation adopted, 2020 WL 5362050 (W.D. Pa. Sept. 8, 2020).
8. DC-ADM 804 mandates that the grievance must include a statement of relevant facts,
including the date, time, and location of events; the identities of any individuals

involved; “any claims the inmate wishes to make concerning violations of DOC
directives, regulations, court orders, or other law; and any compensation or legal relief
desired.” (Doc. 226, at 10, Tr. of Trial, 10:6-9, May 23, 2022). DC-ADM 804
specifically states: “If the inmate desires compensation or other legal relief normally
available from a court, the inmate must request the specific relief sought in his/her initial
grievance.” DC-ADM 804 § 1(A)(11)(d) (emphasis added); (Doc. 226, at 10, Tr. of
Trial, 10:9-12, May 23, 2022).
9. The DC-804, Part 1 grievance form utilized by Davis to file Grievance 664288 informs
inmates to refer to the DOC policy DC-ADM 804 for procedures on the inmate

grievance system and to “[s]tate all relief that you are seeking.” (Doc. 226, at 14-15,
Tr. of Trial, 14:25-15:9, May 23, 2022; Doc. 227, at 2).
10. DOC Defendants assert that because Davis did not request monetary damages in his
initial Grievance 664288, his request for monetary damages must be barred, which
“effectively eliminates the need to proceed with the previously scheduled jury trial.”
(Doc. 225, at 16 n.3).
11. DOC Defendants bear the burden of proof on the exhaustion issue. Rinaldi, 904 F.3d
at 268.
12. Though Davis has pursued other grievances to the final stage of appeal in the

Pennsylvania DOC grievance process, Grievance 664288 is the only one related to this
action – treatment of Davis’s Hepatitis C. (Doc. 226, at 11-14, Tr. of Trial, 11:18-14:2,
May 23, 2022; Doc. 227, at 2).
13. Grievance 664288 does not contain any request for monetary damages or monetary
relief. (Doc. 226, at 15, 26, Tr. of Trial, 15:16-17, 26:1-10, May 23, 2022; Doc. 227, at

2).
14. Since “[i]t is the prison's requirements, and not the PLRA, that defines the boundaries
of proper exhaustion,” a prisoner who fails to request monetary damages in the
grievance process is barred from bringing a claim for monetary relief in federal court.
Smith v. Sec'y of Pa. Dep't of Corr., 747 F. App’x 101, 103 (3d Cir. 2018) (citing Jones v.
Bock, 549 U.S. 199, 218 (2007)).
15. In the absence of competent proof that Davis was misled by corrections officials, or
some other extraordinary circumstances warranting a departure from strict compliance
with the exhaustion requirement, the Court shall reject Davis’s request for his failure

to exhaust to be excused. See Kendrick v. Hann, No. 1:19-CV-01642, 2021 WL 2914986,
at *5 (M.D. Pa. July 12, 2021).
II. ADMINISTRATIVE REMEDIES WERE “UNAVAILABLE” TO DAVIS
16. “[O]nce the defendant has established that the inmate failed to resort to administrative
remedies, the onus falls on the inmate to show that such remedies were unavailable to
him.” See Rinaldi, 904 F.3d at 268 (citing Tuckel, 660 F.3d at 1253-54).
17. “There is one exception to the mandatory exhaustion requirement: administrative
remedies must be available to the prisoner.” Downey v. Pa. Dept. of Corr., 968 F.3d 299,
305 (3d Cir. 2020) (citing Ross v. Blake, 578 U.S. 632, 641 (2016)); see also Johnson v.
Wireman, 809 F. App'x 97, 100 (3d Cir. 2020) (“[A] prisoner need exhaust only
available administrative remedies.” (internal quotations omitted)).
18. Accordingly, the exhaustion requirement “hinges on the ‘availab[ility]’ of
administrative remedies: An inmate, that is, must exhaust available remedies, but need

not exhaust unavailable ones.” Ross, 136 S. Ct. at 1858-59. The Supreme Court has
described “three kinds of circumstances in which an administrative remedy, although
officially on the books, is not capable of use to obtain relief.” Ross, 136 S. Ct. at 1859.
19. First, the Court noted that “an administrative procedure is unavailable when (despite
what regulations or guidance materials may promise) it operates as a simple dead
end—with officers unable or consistently unwilling to provide any relief to aggrieved
inmates.” Ross, 136 S. Ct. at 1859.
20. Second, the Court imagined an administrative scheme that “might be so opaque that
it becomes, practically speaking, incapable of use. In this situation, some mechanism

exists to provide relief, but no ordinary prisoner can discern or navigate it.” Ross, 136
S. Ct. at 1859; see Shifflett v. Korzniak, 934 F.3d 356, 365 (3d. Cir. 2019). The Court
explained that if an administrative process is “susceptible of multiple reasonable
interpretations, Congress has determined that the inmate should err on the side of
exhaustion;” however, if a remedy is “essentially ‘unknowable’—so that no ordinary
prisoner can make sense of what it demands—then it is also unavailable.” Ross, 136 S.
Ct. at 1859.
21. The third situation arises “when prison administrators thwart inmates from taking
advantage of a grievance process through machination, misrepresentation, or

intimidation.” Ross, 136 S. Ct. at 1860.
22. Davis raises several arguments as to why his failure to include a request for monetary
damages in the initial filing of Grievance 664288 should not bar compensatory relief
in this action.4
23. First, Davis argues that “nothing in Grievance System Policy (Inmate Handbook,

2017 Edition) would have put [Davis] on notice that he had to ask for monetary
damages – or any particular form of relief at all.” (Doc. 221, at 5). Nevertheless, Davis
avers that “there was substantial compliance by virtue [because] monetary
relief/damages was sought on appeal.” (Doc. 221, at 8). Davis submits:
Assuming, arguendo, [Davis] was required to include monetary
damages in the initial grievance, the Inmate Handbook, 2017 Edition
impeded/thwarted him from doing do by the removal of that portion of
the handbook, then stating:
“When DOC polities are changed you will be given notice of the
change(s) and the most current policy will become effective,
regardless of what information is in this handbook.”

(Doc. 221, at 7).

24. Davis may not avoid this exhaustion requirement by merely alleging that the
administrative policies were not clearly explained to him. See Davis v. Warman, 49 F.
App'x 365, 368 (3d Cir. 2002).

4 At the non-jury trial, Davis argued that his failure to request monetary damages
should be excused under “vicarious exhaustion.” (Doc. 226, at 35-36, Tr. of Trial, 35:19-36:1,
May 23, 2022). Under the doctrine of vicarious exhaustion, “a class of prisoner-plaintiffs
certified under Rule 23(b)(2) satisfies the PLRA’s administrative exhaustion requirement[,]
when one or more class members ha[s] exhausted his administrative remedies with respect to
each claim raised by the class.” Chandler v. Crosby, 379 F.3d 1278, 1287 (11th Cir. 2004)). In
support of his argument, Davis relied on Chimenti v. Wetzel, No. 15-CV-3333, 2018 WL
3388305 (E.D. Pa. July 12, 2018). (Doc. 226, at 36-38, Tr. of Trial, 36:9-38:20, May 23,
2022).). In Chimenti, the action was filed on behalf of a class of inmates requesting injunctive,
not monetary, relief in the form of Hepatitis C treatment. 2018 WL 3388305, at *6. Davis’s
reliance on Chimenti is misplaced because Davis is the only plaintiff in the present action, and
Davis is seeking monetary damages on his own behalf. (Doc. 112). Therefore, the vicarious
exhaustion doctrine does not apply in this case.
25. “[I]gnorance and confusion regarding the Pennsylvania DOC policies do[ ] not excuse
failing to adhere to these requirements.” Camacho v. Beers, 2018 WL 6618410, at *3
(W.D. Pa. Dec. 18, 2018) (granting summary judgment on exhaustion grounds when
plaintiff failed to request monetary relief in his grievances) (quoting Stokes v.

Wenerowicz, 2017 WL 3226863, at *4 (E.D. Pa. Jul. 31, 2017)).
26. At the non-jury trial, House offered testimony regarding the inmate handbook in
Davis’s possession when he filed Grievance 664288, which informed inmates that they
are responsible for all policies that apply to them. (Doc. 226, at 7, Tr. of Trial, 7:20-
23, May 23, 2022).
27. House testified that the initial grievance form of Grievance 664288 contains the
following instruction:
Refer to the DC-ADM 804 for procedures on the Inmate Grievance
System. State your grievance in Block A in a brief and understandable
manner. List in Block B any action you may have taken to resolve this
matter. Be sure to include the identity of staff members you have
contacted. [. . .] Provide a brief clear statement of your grievance. [. . .]
State all relief that you are seeking.

(Doc. 226, at 14-15, Tr. of Trial, 14:24-15:9, May 23, 2022; Doc. 227,
at 2) (emphasis added).

28. Davis may not excuse a failure to comply with these grievance procedures in a timely
manner by simply claiming that his efforts constituted “substantial compliance” with
this statutory exhaustion requirement. See Harris v. Armstrong, 149 F. App'x 58, 59 (3d
Cir. 2005); see also, e.g., Mack v. Klopotoski, 540 F. App’x 108, 113 (3d Cir. 2013)
(finding procedural default and rejecting inmate's substantial compliance argument
because he failed to provide photocopies of grievances and responses when pursuing
appeal as required by policy).
29. Davis's confusion regarding these grievances procedures does not, alone, excuse a
failure to exhaust. See Casey v. Smith, 71 F. App'x 916 (3d Cir. 2003); see also Marsh v.
Soares, 223 F.3d 1217, 1220 (10th Cir. 2000) (“[I]t is well established that ‘ignorance
of the law, even for an incarcerated pro se petitioner, generally does not excuse prompt

filing.’ ” (citations omitted)).
30. Next, Davis testified at the non-jury trial that DOC Defendants made representations
that “thwarted” is ability to exhaust administrative remedies. (Doc. 226, at 26, Tr. of
Trial, 26:11-24, May 23, 2022).
31. To defeat a failure-to-exhaust defense based upon a prison official’s misrepresentation,
the Third Circuit established that:
an inmate must show (1) that the misrepresentation is one which a
reasonable inmate would be entitled to rely on and sufficiently
misleading to interfere with a reasonable inmate's use of the grievance
process, and (2) that the inmate was actually misled by the
misrepresentation.

Hardy v. Shaikh, 959 F.3d 578, 588 (3d Cir. 2020).
32. In Hardy, the Third Circuit adopted a two-part test to determine whether a
misrepresentation by a prison official thwarted an inmate's use of the grievance
process.
As an objective matter, taking account of the speaker and context, the
instruction must be of the sort that a reasonable inmate would be
“entitled to rely on,” even though it is “at odds with the wording” of the
grievance process. Brown [v. Croak, 312 F.3d 109, 112 (3d Cir. 2002)];
see also Davis [v. Fernandez, 798 F.3d 290, 296 (5th Cir. 2015)] (finding
“no reason that [the inmate] should not be entitled to rely on the
representations of his jailers”). It also must be so misleading to a
reasonable inmate as to interfere with his use of the grievance
process . . . .

As a subjective matter, the inmate must persuade the district court that
he in fact did rely on the misrepresentation to his detriment. As in the
threat context, Rinaldi, 904 F.3d at 268-69, objectively misleading
instructions can be circumstantial evidence that an inmate's use of the
grievance process has been thwarted, but a further showing—such as
“documents, affidavits, or live testimony if deemed warranted,” id. at
269—will typically be required. And in any event, that circumstantial
evidence can be overcome by evidence that an inmate actually knew
how to navigate the grievance process despite the misleading
instructions. Id.; cf. Dillon v. Rogers, 596 F.3d 260, 268 (5th Cir. 2010)
(“When a prisoner has no means of verifying prison officials’ claims
about the administrative grievance process, incorrect statements by
officials may indeed make remedies unavailable.”).

Hardy, 959 F.3d at 587-88.
33. Davis satisfies the first, objective prong because DOC Defendants engaged in conduct
was “sufficiently misleading to interfere with a reasonable inmate’s use of the
grievance system.” Hardy, 959 F.3d at 588.
34. At the non-jury trial, Davis testified that DOC Defendants “thwarted” his ability to
request monetary relief because DOC Defendants placed him under the impression
that he did not have to request monetary damages because his request for Hepatitis C
treatment would be sent to the Committee. (Doc. 226, at 28, Tr. of Trial, 28:17-23,
May 23, 2022).
35. Davis testified that based on Rankin’s response to Davis’s DC-135A informal inmate
request to staff letter, he was under the assumption that SCI-Fayette did not provide
Hepatitis C treatment. (Doc. 226, at 22-23, Tr. of Trial, 22:18-23:14, May 23, 2022).
36. Davis testified that he decided to file Grievance 664288 in an attempt to determine
who was on the Committee and formally request Hepatitis C treatment. (Doc. 226, at
23, Tr. of Trial, 23:15-21, May 23, 2022).
37. Davis explained that Grievance 664288 does not request monetary damages because
he was under the assumption that “they w[ere] giving everybody the programs and all
this stuff, and [he was] asking for just the treatment. . . .” (Doc. 226, at 30, Tr. of Trial,
30:6-13, May 23, 2022).
38. However, after Grievance 664288 was initially denied, Davis testified: he “realized
that something else was going on, [he] started asking them for funds. [He] said if [he]

get[s] hurt from what you all doing, [he] deserve[s] funds.” (Doc. 226, at 33, Tr. of
Trial, 33:4-6, May 23, 2022).
39. Davis sought monetary relief in each appeal of Grievance 664288 filed thereafter.
(Doc. 226, at 27, Tr. of Trial, 27:1-11, May 23, 2022).
40. Davis contends that DOC Defendants misled him by addressing Grievance 664288 on
the merits “even after [Davis] mentioned the funds in the appeal to the
Superintendent.” (Doc. 226, at 27, Tr. of Trial, 27:5-20, May 23, 2022).
41. Davis testified that “if [DOC Defendants] addressed it on the merits, all the way up
until now . . . that exhaustion procedure is completed . . . .” (Doc. 226, at 31, Tr. of
Trial, 31:12-13, May 23, 2022).

42. Davis argues that DOC Defendants’ failed to raise the failure-to-exhaust defense until
the motion to bifurcate was filed on February 7, 2022, four and a half years after Davis
initiated this matter. (Doc. 5; Doc. 207; Doc. 226, at 30-31, Tr. of Trial, 30:23-31:8,
May 23, 2022).
43. Based on the DOC’s representations regarding the existence of the Committee and a
Court Order that inmates should receive Hepatitis C treatment, a reasonable inmate
could have concluded that no additional relief must be requested if the only relief
sought is treatment even though it is “at odds with the wording” of the grievance
process. Hardy, 959 F.3d at 587-88.
44. Furthermore, based on DOC Defendants’ representations regarding ongoing
administrative action in response to Grievance 664288 and the present action, a
reasonable inmate could have concluded that no further action was required to pursue
his grievance – particularly given that Davis actively pursued monetary relief in all

subsequent filings. Hardy, 959 F.3d at 587-88; see Freeman, 2020 WL 6730897, at *10
(finding that prisoner satisfied the Hardy test where he was repeatedly advised by DOC
officials that the investigation of his attack was ongoing).
45. Davis also satisfies the second, subjective prong because there is sufficient evidence to
establish that Davis was actually misled by DOC Defendants’ representations. See
Hardy, 959 F.3d at 587-88.
46. DOC Defendants argue that Davis was not actually misled by their representations
regarding the grievance process because Davis filed prior grievances in which he
properly requested compensation in the initial grievances. (Doc. 225, at 9). DOC

Defendants argue that there is sufficient evidence to establish Davis “knew how to
navigate the grievance process and had properly done so on a number of prior
occasions.” (Doc. 225, at 10).
47. At the non-jury trial, Davis testified that the response from Rankin on behalf of
Superintendent Lane misled him by indicating that the Committee was responsible
with deciding which inmates receive Hepatitis C treatment. (Doc. 226, at 22-23, Tr. of
Trial, 22:18-23:14, May 23, 2022).
48. Davis explained that he did not initially seek compensation because he was under the
assumption that the Committee would grant him medical attention as required by the

decree of Judge Mariani. (Doc. 226, at 22-23, Tr. of Trial, 22:18-23:14, May 23, 2022).
49. However, after Grievance 664288 was initially denied and failed to identify the
members of the Committee, Davis testified that DOC Defendants thwarted his ability
to exhaust all “available” administrative remedies. (Doc. 226, at 30, Tr. of Trial, 30:6-
13, May 23, 2022).

50. Thereafter, Davis sought monetary relief in every appeal of Grievance 664288. (Doc.
226, at 27, Tr. of Trial, 27:1-11, May 23, 2022).
51. Accordingly, Davis did in fact rely on DOC Defendants’ misrepresentations to Davis’s
detriment. See Hardy, 959 F.3d at 587-88.
52. In addition, Davis testified that DOC Defendants’ actions misled him by addressing
Grievance 664288 on the merits through various appeals without raising a challenge
to Davis requesting monetary relief in his appeals. (Doc. 226, at 27, 29, Tr. of Trial,
27:12-20, 29:18-23, May 23, 2022).
53. Davis argues that DOC Defendants should have rejected his grievance for failure to

comply with DC-ADM 804, as opposed to denying it on the merits. (Doc. 221, at 8;
Doc. 226, at 29, 31, Tr. of Trial, 29:18-23, 31:9-17, May 23, 2022).
54. Davis testified that “if [DOC Defendants] addressed it on the merits, all the way up
until now . . . that exhaustion procedure is completed . . . .” (Doc. 226, at 31, Tr. of
Trial, 31:12-13, May 23, 2022).
55. Davis has satisfied both the objective and subjective prongs of the test articulated by
the Third Circuit in Hardy, 959 F.3d at 587-88.
56. DOC Defendants’ misleading conduct rendered the PLRA exhaustion of
administrative remedies process “unavailable” to Davis. See Hardy, 959 F.3d at 587-

88; see also Ross, 136 S. Ct. at 1859.
57. Davis has met the required burden to defeat the failure-to-exhaust defense raised by
DOC Defendants. See Rinaldi, 904 F.3d at 268.
58. A genuine issue of material fact exists as to whether the DOC Defendants provided
misleading information to Davis that rendered the grievance process “unavailable” to

him. See Millhouse v. United States, No. 1:19-CV-00665, 2021 WL 2412930, at *11
(M.D. Pa. June 14, 2021) (finding that genuine issue of fact existed as to whether
grievance process was rendered unavailable to plaintiff); Freeman, 2020 WL 6730897,
at *10.
59. The Court declines to grant summary judgment on the basis of failure to exhaust
administrative remedies.
60. Davis’s request for monetary damages is not barred.
CONCLUSION
For the foregoing reasons, the Court concludes that Davis’s request for monetary
damages is not barred. (Doc. 112, at 12). Accordingly, DOC Defendants’ request for

summary judgment on the basis of failure to exhaust administrative remedies is DENIED.
(Doc. 207; Doc. 225).
An appropriate Order follows.

BY THE COURT:

Dated: July 6, 2022 s/ Karoline Mehalchick
KAROLINE MEHALCHICK
Chief United States Magistrate Judge

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/cases/10411916. Public record. Not legal advice.